ArticleCardio-oncology (London, England)2021

Pre-existing cardiovascular disease increases risk of atrial arrhythmia and mortality in cancer patients treated with Ibrutinib.

Juan Carlo Avalon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.